
Please try another search
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company was incorporated in 2009 and is headquartered in Vancouver, Canada.
Name | Age | Since | Title |
---|---|---|---|
Richard M. Glickman | 67 | 2010 | Independent Chairman of the Board |
David Ross Parkinson | 75 | 2015 | President, CEO & Director |
Raymond Andersen | 78 | 2009 | Scientific Advisor |
Marianne D. Sadar | 64 | 2009 | Scientific Advisor |
Sanford S. Zweifach | 69 | 2019 | Independent Director |
Franklin M. Berger | 76 | 2015 | Independent Director |
Scott Requadt | 57 | 2016 | Independent Director |
Marella Thorell | 58 | 2019 | Independent Director |
John Alexander Martin | 57 | 2019 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review